Global Venous Thromboembolism Treatment Options Supply, Demand and Key Producers, 2023-2029

Page: 95

Published Date: 04 Sep 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Venous Thromboembolism Treatment Options market size is expected to reach $ 462 million by 2029, rising at a market growth of 3.3% CAGR during the forecast period (2023-2029).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The most common treatment for deep vein thrombosis is the use of anticoagulants, also known as blood thinners. These medicines, which can be taken by injection or pill, can reduce your blood's ability to clot. They don't break down existing clots, but they prevent them from getting bigger and reduce the risk of more clots forming. Injectable drugs can be given either subcutaneously or intravenously.

This report studies the global Venous Thromboembolism Treatment Options production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Venous Thromboembolism Treatment Options, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Venous Thromboembolism Treatment Options that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Venous Thromboembolism Treatment Options total production and demand, 2018-2029, (K Units)
Global Venous Thromboembolism Treatment Options total production value, 2018-2029, (USD Million)
Global Venous Thromboembolism Treatment Options production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Venous Thromboembolism Treatment Options consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Venous Thromboembolism Treatment Options domestic production, consumption, key domestic manufacturers and share
Global Venous Thromboembolism Treatment Options production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Venous Thromboembolism Treatment Options production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Venous Thromboembolism Treatment Options production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Venous Thromboembolism Treatment Options market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AngioDynamics, Cardinal Health Inc., BTG International Ltd., Stryker Corporation, DJO Global Inc., EKOS Corp, Teleflex Inc., Boston Scientific Corp. and Janssen Pharmaceuticals, Inc, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Venous Thromboembolism Treatment Options market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Venous Thromboembolism Treatment Options Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Venous Thromboembolism Treatment Options Market, Segmentation by Type
Upper Pneumatic Compression Sleeves
Lower Pneumatic Compression Sleeves
Permanent Inferior Vena Cava Filters
Others

Global Venous Thromboembolism Treatment Options Market, Segmentation by Application
Hospitals
Catheterisation Laboratories
Ambulatory Surgical Centers

Companies Profiled:
AngioDynamics
Cardinal Health Inc.
BTG International Ltd.
Stryker Corporation
DJO Global Inc.
EKOS Corp
Teleflex Inc., Boston Scientific Corp.
Janssen Pharmaceuticals, Inc

Key Questions Answered
1. How big is the global Venous Thromboembolism Treatment Options market?
2. What is the demand of the global Venous Thromboembolism Treatment Options market?
3. What is the year over year growth of the global Venous Thromboembolism Treatment Options market?
4. What is the production and production value of the global Venous Thromboembolism Treatment Options market?
5. Who are the key producers in the global Venous Thromboembolism Treatment Options market?

Table of Contents

1 Supply Summary
    1.1 Venous Thromboembolism Treatment Options Introduction
    1.2 World Venous Thromboembolism Treatment Options Supply & Forecast
        1.2.1 World Venous Thromboembolism Treatment Options Production Value (2018 & 2022 & 2029)
        1.2.2 World Venous Thromboembolism Treatment Options Production (2018-2029)
        1.2.3 World Venous Thromboembolism Treatment Options Pricing Trends (2018-2029)
    1.3 World Venous Thromboembolism Treatment Options Production by Region (Based on Production Site)
        1.3.1 World Venous Thromboembolism Treatment Options Production Value by Region (2018-2029)
        1.3.2 World Venous Thromboembolism Treatment Options Production by Region (2018-2029)
        1.3.3 World Venous Thromboembolism Treatment Options Average Price by Region (2018-2029)
        1.3.4 North America Venous Thromboembolism Treatment Options Production (2018-2029)
        1.3.5 Europe Venous Thromboembolism Treatment Options Production (2018-2029)
        1.3.6 China Venous Thromboembolism Treatment Options Production (2018-2029)
        1.3.7 Japan Venous Thromboembolism Treatment Options Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Venous Thromboembolism Treatment Options Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Venous Thromboembolism Treatment Options Major Market Trends

2 Demand Summary
    2.1 World Venous Thromboembolism Treatment Options Demand (2018-2029)
    2.2 World Venous Thromboembolism Treatment Options Consumption by Region
        2.2.1 World Venous Thromboembolism Treatment Options Consumption by Region (2018-2023)
        2.2.2 World Venous Thromboembolism Treatment Options Consumption Forecast by Region (2024-2029)
    2.3 United States Venous Thromboembolism Treatment Options Consumption (2018-2029)
    2.4 China Venous Thromboembolism Treatment Options Consumption (2018-2029)
    2.5 Europe Venous Thromboembolism Treatment Options Consumption (2018-2029)
    2.6 Japan Venous Thromboembolism Treatment Options Consumption (2018-2029)
    2.7 South Korea Venous Thromboembolism Treatment Options Consumption (2018-2029)
    2.8 ASEAN Venous Thromboembolism Treatment Options Consumption (2018-2029)
    2.9 India Venous Thromboembolism Treatment Options Consumption (2018-2029)

3 World Venous Thromboembolism Treatment Options Manufacturers Competitive Analysis
    3.1 World Venous Thromboembolism Treatment Options Production Value by Manufacturer (2018-2023)
    3.2 World Venous Thromboembolism Treatment Options Production by Manufacturer (2018-2023)
    3.3 World Venous Thromboembolism Treatment Options Average Price by Manufacturer (2018-2023)
    3.4 Venous Thromboembolism Treatment Options Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Venous Thromboembolism Treatment Options Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Venous Thromboembolism Treatment Options in 2022
        3.5.3 Global Concentration Ratios (CR8) for Venous Thromboembolism Treatment Options in 2022
    3.6 Venous Thromboembolism Treatment Options Market: Overall Company Footprint Analysis
        3.6.1 Venous Thromboembolism Treatment Options Market: Region Footprint
        3.6.2 Venous Thromboembolism Treatment Options Market: Company Product Type Footprint
        3.6.3 Venous Thromboembolism Treatment Options Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Venous Thromboembolism Treatment Options Production Value Comparison
        4.1.1 United States VS China: Venous Thromboembolism Treatment Options Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Venous Thromboembolism Treatment Options Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Venous Thromboembolism Treatment Options Production Comparison
        4.2.1 United States VS China: Venous Thromboembolism Treatment Options Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Venous Thromboembolism Treatment Options Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Venous Thromboembolism Treatment Options Consumption Comparison
        4.3.1 United States VS China: Venous Thromboembolism Treatment Options Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Venous Thromboembolism Treatment Options Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Venous Thromboembolism Treatment Options Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Venous Thromboembolism Treatment Options Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Venous Thromboembolism Treatment Options Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Venous Thromboembolism Treatment Options Production (2018-2023)
    4.5 China Based Venous Thromboembolism Treatment Options Manufacturers and Market Share
        4.5.1 China Based Venous Thromboembolism Treatment Options Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Venous Thromboembolism Treatment Options Production Value (2018-2023)
        4.5.3 China Based Manufacturers Venous Thromboembolism Treatment Options Production (2018-2023)
    4.6 Rest of World Based Venous Thromboembolism Treatment Options Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Venous Thromboembolism Treatment Options Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Venous Thromboembolism Treatment Options Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Venous Thromboembolism Treatment Options Production (2018-2023)

5 Market Analysis by Type
    5.1 World Venous Thromboembolism Treatment Options Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Upper Pneumatic Compression Sleeves
        5.2.2 Lower Pneumatic Compression Sleeves
        5.2.3 Permanent Inferior Vena Cava Filters
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World Venous Thromboembolism Treatment Options Production by Type (2018-2029)
        5.3.2 World Venous Thromboembolism Treatment Options Production Value by Type (2018-2029)
        5.3.3 World Venous Thromboembolism Treatment Options Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Venous Thromboembolism Treatment Options Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospitals
        6.2.2 Catheterisation Laboratories
        6.2.3 Ambulatory Surgical Centers
    6.3 Market Segment by Application
        6.3.1 World Venous Thromboembolism Treatment Options Production by Application (2018-2029)
        6.3.2 World Venous Thromboembolism Treatment Options Production Value by Application (2018-2029)
        6.3.3 World Venous Thromboembolism Treatment Options Average Price by Application (2018-2029)

7 Company Profiles
    7.1 AngioDynamics
        7.1.1 AngioDynamics Details
        7.1.2 AngioDynamics Major Business
        7.1.3 AngioDynamics Venous Thromboembolism Treatment Options Product and Services
        7.1.4 AngioDynamics Venous Thromboembolism Treatment Options Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 AngioDynamics Recent Developments/Updates
        7.1.6 AngioDynamics Competitive Strengths & Weaknesses
    7.2 Cardinal Health Inc.
        7.2.1 Cardinal Health Inc. Details
        7.2.2 Cardinal Health Inc. Major Business
        7.2.3 Cardinal Health Inc. Venous Thromboembolism Treatment Options Product and Services
        7.2.4 Cardinal Health Inc. Venous Thromboembolism Treatment Options Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Cardinal Health Inc. Recent Developments/Updates
        7.2.6 Cardinal Health Inc. Competitive Strengths & Weaknesses
    7.3 BTG International Ltd.
        7.3.1 BTG International Ltd. Details
        7.3.2 BTG International Ltd. Major Business
        7.3.3 BTG International Ltd. Venous Thromboembolism Treatment Options Product and Services
        7.3.4 BTG International Ltd. Venous Thromboembolism Treatment Options Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 BTG International Ltd. Recent Developments/Updates
        7.3.6 BTG International Ltd. Competitive Strengths & Weaknesses
    7.4 Stryker Corporation
        7.4.1 Stryker Corporation Details
        7.4.2 Stryker Corporation Major Business
        7.4.3 Stryker Corporation Venous Thromboembolism Treatment Options Product and Services
        7.4.4 Stryker Corporation Venous Thromboembolism Treatment Options Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Stryker Corporation Recent Developments/Updates
        7.4.6 Stryker Corporation Competitive Strengths & Weaknesses
    7.5 DJO Global Inc.
        7.5.1 DJO Global Inc. Details
        7.5.2 DJO Global Inc. Major Business
        7.5.3 DJO Global Inc. Venous Thromboembolism Treatment Options Product and Services
        7.5.4 DJO Global Inc. Venous Thromboembolism Treatment Options Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 DJO Global Inc. Recent Developments/Updates
        7.5.6 DJO Global Inc. Competitive Strengths & Weaknesses
    7.6 EKOS Corp
        7.6.1 EKOS Corp Details
        7.6.2 EKOS Corp Major Business
        7.6.3 EKOS Corp Venous Thromboembolism Treatment Options Product and Services
        7.6.4 EKOS Corp Venous Thromboembolism Treatment Options Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 EKOS Corp Recent Developments/Updates
        7.6.6 EKOS Corp Competitive Strengths & Weaknesses
    7.7 Teleflex Inc., Boston Scientific Corp.
        7.7.1 Teleflex Inc., Boston Scientific Corp. Details
        7.7.2 Teleflex Inc., Boston Scientific Corp. Major Business
        7.7.3 Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Product and Services
        7.7.4 Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Teleflex Inc., Boston Scientific Corp. Recent Developments/Updates
        7.7.6 Teleflex Inc., Boston Scientific Corp. Competitive Strengths & Weaknesses
    7.8 Janssen Pharmaceuticals, Inc
        7.8.1 Janssen Pharmaceuticals, Inc Details
        7.8.2 Janssen Pharmaceuticals, Inc Major Business
        7.8.3 Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Product and Services
        7.8.4 Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Janssen Pharmaceuticals, Inc Recent Developments/Updates
        7.8.6 Janssen Pharmaceuticals, Inc Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Venous Thromboembolism Treatment Options Industry Chain
    8.2 Venous Thromboembolism Treatment Options Upstream Analysis
        8.2.1 Venous Thromboembolism Treatment Options Core Raw Materials
        8.2.2 Main Manufacturers of Venous Thromboembolism Treatment Options Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Venous Thromboembolism Treatment Options Production Mode
    8.6 Venous Thromboembolism Treatment Options Procurement Model
    8.7 Venous Thromboembolism Treatment Options Industry Sales Model and Sales Channels
        8.7.1 Venous Thromboembolism Treatment Options Sales Model
        8.7.2 Venous Thromboembolism Treatment Options Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Venous Thromboembolism Treatment Options Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Venous Thromboembolism Treatment Options Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Venous Thromboembolism Treatment Options Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Venous Thromboembolism Treatment Options Production Value Market Share by Region (2018-2023)
    Table 5. World Venous Thromboembolism Treatment Options Production Value Market Share by Region (2024-2029)
    Table 6. World Venous Thromboembolism Treatment Options Production by Region (2018-2023) & (K Units)
    Table 7. World Venous Thromboembolism Treatment Options Production by Region (2024-2029) & (K Units)
    Table 8. World Venous Thromboembolism Treatment Options Production Market Share by Region (2018-2023)
    Table 9. World Venous Thromboembolism Treatment Options Production Market Share by Region (2024-2029)
    Table 10. World Venous Thromboembolism Treatment Options Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Venous Thromboembolism Treatment Options Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Venous Thromboembolism Treatment Options Major Market Trends
    Table 13. World Venous Thromboembolism Treatment Options Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Venous Thromboembolism Treatment Options Consumption by Region (2018-2023) & (K Units)
    Table 15. World Venous Thromboembolism Treatment Options Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Venous Thromboembolism Treatment Options Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Venous Thromboembolism Treatment Options Producers in 2022
    Table 18. World Venous Thromboembolism Treatment Options Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Venous Thromboembolism Treatment Options Producers in 2022
    Table 20. World Venous Thromboembolism Treatment Options Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Venous Thromboembolism Treatment Options Company Evaluation Quadrant
    Table 22. World Venous Thromboembolism Treatment Options Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Venous Thromboembolism Treatment Options Production Site of Key Manufacturer
    Table 24. Venous Thromboembolism Treatment Options Market: Company Product Type Footprint
    Table 25. Venous Thromboembolism Treatment Options Market: Company Product Application Footprint
    Table 26. Venous Thromboembolism Treatment Options Competitive Factors
    Table 27. Venous Thromboembolism Treatment Options New Entrant and Capacity Expansion Plans
    Table 28. Venous Thromboembolism Treatment Options Mergers & Acquisitions Activity
    Table 29. United States VS China Venous Thromboembolism Treatment Options Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Venous Thromboembolism Treatment Options Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Venous Thromboembolism Treatment Options Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Venous Thromboembolism Treatment Options Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Venous Thromboembolism Treatment Options Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Venous Thromboembolism Treatment Options Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Venous Thromboembolism Treatment Options Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Venous Thromboembolism Treatment Options Production Market Share (2018-2023)
    Table 37. China Based Venous Thromboembolism Treatment Options Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Venous Thromboembolism Treatment Options Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Venous Thromboembolism Treatment Options Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Venous Thromboembolism Treatment Options Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Venous Thromboembolism Treatment Options Production Market Share (2018-2023)
    Table 42. Rest of World Based Venous Thromboembolism Treatment Options Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Venous Thromboembolism Treatment Options Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Venous Thromboembolism Treatment Options Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Venous Thromboembolism Treatment Options Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Venous Thromboembolism Treatment Options Production Market Share (2018-2023)
    Table 47. World Venous Thromboembolism Treatment Options Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Venous Thromboembolism Treatment Options Production by Type (2018-2023) & (K Units)
    Table 49. World Venous Thromboembolism Treatment Options Production by Type (2024-2029) & (K Units)
    Table 50. World Venous Thromboembolism Treatment Options Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Venous Thromboembolism Treatment Options Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Venous Thromboembolism Treatment Options Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Venous Thromboembolism Treatment Options Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Venous Thromboembolism Treatment Options Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Venous Thromboembolism Treatment Options Production by Application (2018-2023) & (K Units)
    Table 56. World Venous Thromboembolism Treatment Options Production by Application (2024-2029) & (K Units)
    Table 57. World Venous Thromboembolism Treatment Options Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Venous Thromboembolism Treatment Options Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Venous Thromboembolism Treatment Options Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Venous Thromboembolism Treatment Options Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. AngioDynamics Basic Information, Manufacturing Base and Competitors
    Table 62. AngioDynamics Major Business
    Table 63. AngioDynamics Venous Thromboembolism Treatment Options Product and Services
    Table 64. AngioDynamics Venous Thromboembolism Treatment Options Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. AngioDynamics Recent Developments/Updates
    Table 66. AngioDynamics Competitive Strengths & Weaknesses
    Table 67. Cardinal Health Inc. Basic Information, Manufacturing Base and Competitors
    Table 68. Cardinal Health Inc. Major Business
    Table 69. Cardinal Health Inc. Venous Thromboembolism Treatment Options Product and Services
    Table 70. Cardinal Health Inc. Venous Thromboembolism Treatment Options Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Cardinal Health Inc. Recent Developments/Updates
    Table 72. Cardinal Health Inc. Competitive Strengths & Weaknesses
    Table 73. BTG International Ltd. Basic Information, Manufacturing Base and Competitors
    Table 74. BTG International Ltd. Major Business
    Table 75. BTG International Ltd. Venous Thromboembolism Treatment Options Product and Services
    Table 76. BTG International Ltd. Venous Thromboembolism Treatment Options Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. BTG International Ltd. Recent Developments/Updates
    Table 78. BTG International Ltd. Competitive Strengths & Weaknesses
    Table 79. Stryker Corporation Basic Information, Manufacturing Base and Competitors
    Table 80. Stryker Corporation Major Business
    Table 81. Stryker Corporation Venous Thromboembolism Treatment Options Product and Services
    Table 82. Stryker Corporation Venous Thromboembolism Treatment Options Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Stryker Corporation Recent Developments/Updates
    Table 84. Stryker Corporation Competitive Strengths & Weaknesses
    Table 85. DJO Global Inc. Basic Information, Manufacturing Base and Competitors
    Table 86. DJO Global Inc. Major Business
    Table 87. DJO Global Inc. Venous Thromboembolism Treatment Options Product and Services
    Table 88. DJO Global Inc. Venous Thromboembolism Treatment Options Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. DJO Global Inc. Recent Developments/Updates
    Table 90. DJO Global Inc. Competitive Strengths & Weaknesses
    Table 91. EKOS Corp Basic Information, Manufacturing Base and Competitors
    Table 92. EKOS Corp Major Business
    Table 93. EKOS Corp Venous Thromboembolism Treatment Options Product and Services
    Table 94. EKOS Corp Venous Thromboembolism Treatment Options Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. EKOS Corp Recent Developments/Updates
    Table 96. EKOS Corp Competitive Strengths & Weaknesses
    Table 97. Teleflex Inc., Boston Scientific Corp. Basic Information, Manufacturing Base and Competitors
    Table 98. Teleflex Inc., Boston Scientific Corp. Major Business
    Table 99. Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Product and Services
    Table 100. Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Teleflex Inc., Boston Scientific Corp. Recent Developments/Updates
    Table 102. Janssen Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
    Table 103. Janssen Pharmaceuticals, Inc Major Business
    Table 104. Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Product and Services
    Table 105. Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 106. Global Key Players of Venous Thromboembolism Treatment Options Upstream (Raw Materials)
    Table 107. Venous Thromboembolism Treatment Options Typical Customers
    Table 108. Venous Thromboembolism Treatment Options Typical Distributors
List of Figure
    Figure 1. Venous Thromboembolism Treatment Options Picture
    Figure 2. World Venous Thromboembolism Treatment Options Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Venous Thromboembolism Treatment Options Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Venous Thromboembolism Treatment Options Production (2018-2029) & (K Units)
    Figure 5. World Venous Thromboembolism Treatment Options Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Venous Thromboembolism Treatment Options Production Value Market Share by Region (2018-2029)
    Figure 7. World Venous Thromboembolism Treatment Options Production Market Share by Region (2018-2029)
    Figure 8. North America Venous Thromboembolism Treatment Options Production (2018-2029) & (K Units)
    Figure 9. Europe Venous Thromboembolism Treatment Options Production (2018-2029) & (K Units)
    Figure 10. China Venous Thromboembolism Treatment Options Production (2018-2029) & (K Units)
    Figure 11. Japan Venous Thromboembolism Treatment Options Production (2018-2029) & (K Units)
    Figure 12. Venous Thromboembolism Treatment Options Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Venous Thromboembolism Treatment Options Consumption (2018-2029) & (K Units)
    Figure 15. World Venous Thromboembolism Treatment Options Consumption Market Share by Region (2018-2029)
    Figure 16. United States Venous Thromboembolism Treatment Options Consumption (2018-2029) & (K Units)
    Figure 17. China Venous Thromboembolism Treatment Options Consumption (2018-2029) & (K Units)
    Figure 18. Europe Venous Thromboembolism Treatment Options Consumption (2018-2029) & (K Units)
    Figure 19. Japan Venous Thromboembolism Treatment Options Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Venous Thromboembolism Treatment Options Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Venous Thromboembolism Treatment Options Consumption (2018-2029) & (K Units)
    Figure 22. India Venous Thromboembolism Treatment Options Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Venous Thromboembolism Treatment Options by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Venous Thromboembolism Treatment Options Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Venous Thromboembolism Treatment Options Markets in 2022
    Figure 26. United States VS China: Venous Thromboembolism Treatment Options Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Venous Thromboembolism Treatment Options Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Venous Thromboembolism Treatment Options Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Venous Thromboembolism Treatment Options Production Market Share 2022
    Figure 30. China Based Manufacturers Venous Thromboembolism Treatment Options Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Venous Thromboembolism Treatment Options Production Market Share 2022
    Figure 32. World Venous Thromboembolism Treatment Options Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Venous Thromboembolism Treatment Options Production Value Market Share by Type in 2022
    Figure 34. Upper Pneumatic Compression Sleeves
    Figure 35. Lower Pneumatic Compression Sleeves
    Figure 36. Permanent Inferior Vena Cava Filters
    Figure 37. Others
    Figure 38. World Venous Thromboembolism Treatment Options Production Market Share by Type (2018-2029)
    Figure 39. World Venous Thromboembolism Treatment Options Production Value Market Share by Type (2018-2029)
    Figure 40. World Venous Thromboembolism Treatment Options Average Price by Type (2018-2029) & (US$/Unit)
    Figure 41. World Venous Thromboembolism Treatment Options Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 42. World Venous Thromboembolism Treatment Options Production Value Market Share by Application in 2022
    Figure 43. Hospitals
    Figure 44. Catheterisation Laboratories
    Figure 45. Ambulatory Surgical Centers
    Figure 46. World Venous Thromboembolism Treatment Options Production Market Share by Application (2018-2029)
    Figure 47. World Venous Thromboembolism Treatment Options Production Value Market Share by Application (2018-2029)
    Figure 48. World Venous Thromboembolism Treatment Options Average Price by Application (2018-2029) & (US$/Unit)
    Figure 49. Venous Thromboembolism Treatment Options Industry Chain
    Figure 50. Venous Thromboembolism Treatment Options Procurement Model
    Figure 51. Venous Thromboembolism Treatment Options Sales Model
    Figure 52. Venous Thromboembolism Treatment Options Sales Channels, Direct Sales, and Distribution
    Figure 53. Methodology
    Figure 54. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

AngioDynamics
Cardinal Health Inc.
BTG International Ltd.
Stryker Corporation
DJO Global Inc.
EKOS Corp
Teleflex Inc., Boston Scientific Corp.
Janssen Pharmaceuticals, Inc

Related Reports

Global Venous Thromboembolism Treatment Options Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Venous Thromboembolism Treatment Options Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 04 Sep 2023

date Medical Care

According to our (Global Info Research) latest study, the global Venous Thromboembolism Treatment Options market size was valued at USD 366.8 million in 2022 and is forecast to a readjusted size of USD 462 million by 2029 with a CAGR of 3.3% during review period.

Global Venous Thromboembolism Treatment Options Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Venous Thromboembolism Treatment Options Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 17 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Venous Thromboembolism Treatment Options market size was valued at USD 366.8 million in 2023 and is forecast to a readjusted size of USD 462 million by 2030 with a CAGR of 3.3% during review period.

Product Tags

Venous Thromboembolism Treatment Options

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>